Wolverine Trading’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-26,266
Closed -$1.84M 5413
2024
Q3
$1.75M Buy
+26,266
New +$1.91M ﹤0.01% 1816
2024
Q2
Sell
-3,549
Closed -$314K 4668
2024
Q1
$339K Buy
3,549
+902
+34% +$75.8K ﹤0.01% 3220
2023
Q4
$202K Buy
+2,647
New +$184K ﹤0.01% 3868
2023
Q1
Sell
-9,395
Closed -$738K 4440
2022
Q4
$701K Sell
9,395
-6,449
-41% -$497K ﹤0.01% 2102
2022
Q3
$1.33M Buy
+15,844
New +$1.52M ﹤0.01% 1726
2022
Q2
Sell
-10,418
Closed -$1.08M 4842
2022
Q1
$1.22M Buy
+10,418
New +$1.17M ﹤0.01% 2239
2021
Q4
Sell
-17,646
Closed -$2M 6149
2021
Q3
$2M Buy
+17,646
New +$2.01M ﹤0.01% 2150
2021
Q2
Sell
-9,270
Closed -$768K 6200
2021
Q1
$768K Buy
+9,270
New +$784K ﹤0.01% 3104
2020
Q2
Sell
-12,177
Closed -$796K 4737
2020
Q1
$796K Sell
12,177
-36,102
-75% -$2.6M ﹤0.01% 2150
2019
Q4
$3.74M Buy
48,279
+25,899
+116% +$2.02M 0.01% 1329
2019
Q3
$1.62M Buy
+22,380
New +$1.57M ﹤0.01% 1581
2018
Q3
Sell
-8,244
Closed -$403K 5172
2018
Q2
$383K Hold
8,244
﹤0.01% 3426
2018
Q1
$383K Buy
+8,244
New +$358K ﹤0.01% 3426
2017
Q2
Sell
-32,289
Closed -$1.18M 4438
2017
Q1
$1.01M Sell
32,289
-26,658
-45% -$835K 0.01% 1712
2016
Q4
$1.84M Buy
+58,947
New +$1.91M 0.01% 1404

Other funds holding EW

Wolverine Trading's EW Position: Q4 2024 in Review

Wolverine Trading sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 26,266 shares — an estimated $1.84M sold.

Wolverine Trading first reported a position in EW in Q4 2016 and held it in 15 quarters. The position peaked at $3.74M in Q4 2019. 1,226 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Wolverine Trading reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 26,266 Edwards Lifesciences shares in Q4 2024, an estimated $1.84M.
  • Wolverine Trading first reported a position in Edwards Lifesciences in Q4 2016 and held it in 15 quarters.
  • Wolverine Trading's Edwards Lifesciences position peaked at $3.74M in Q4 2019.
  • 1,226 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.